Targeting therapy for breast carcinoma by ATP synthase inhibitor aurovertin b

Tsui Chin Huang, Hsin Yi Chang, Chun Hua Hsu, Wen Hung Kuo, King Jen Chang, Hsueh Fen Juan

研究成果: 雜誌貢獻文章同行評審

93 引文 斯高帕斯(Scopus)


Targeting of tumor tissues is one of the most powerful approaches to accelerate the efficiency of anticancer treatments. The investigation of effective targets, including proteins specifically and abundantly expressed in abnormal regions, has been one of the most important research topics in cancer therapy. In this study, we performed a proteomic analysis on human breast carcinoma tissues to investigate the tumor-specific protein expression in breast carcinoma. Our study showed that ATP synthase was up-regulated in tumor tissues and was present on the plasma membrane of breast cancer cells. Furthermore, we treated the breast cancer cells with ATP synthase inhibitors and examined the inhibitory efficiency. Aurovertin B, an ATP synthase inhibitor, has strong inhibition on the proliferation of several breast cancer cell lines, but little influence on the normal cell line MCF-10A. Aurovertin B inhibits proliferation of breast cancer cells by inducing apoptosis and arresting cell cycle at the G0/G1 phase. This study showed aurovertin B can be used as an antitumorigenic agent and may be exploited in cancer chemotherapy.
頁(從 - 到)1433-1444
期刊Journal of Proteome Research
出版狀態已發佈 - 4月 2008

ASJC Scopus subject areas

  • 生物化學
  • 化學 (全部)
  • 遺傳學
  • 生物技術


深入研究「Targeting therapy for breast carcinoma by ATP synthase inhibitor aurovertin b」主題。共同形成了獨特的指紋。